Showing results (421-430 of 480) with videos related to
Sort By:
Pageof 48
Nature Communications|June 7, 2022
Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockadeAkshay J Patel, Zena N Willsmore, Naeem Khan, et al.Pain|November 26, 2008
Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injuryP J Wrigley, S R Press, S M Gustin, et al.Bone Marrow Transplantation|November 1, 1996
Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescueB C Millar, J L Millar, J B Bell, et al.Blood|November 15, 1991
Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1D T Wong, A Elovic, K Matossian, et al.The Journal of Clinical Investigation|June 1, 1993
Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alphaJ J Costa, K Matossian, M B Resnick, et al.European Journal of Pharmacology|April 1, 1979
Dopaminergic effects of non-hydroxylated rigid analogs of apomorphineD B Rusterholz, J P Long, J R Flynn, et al.Molecular and Cellular Biology|August 11, 2000
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated proteinS Shintani, H Ohyama, X Zhang, et al.The Journal of Experimental Medicine|September 1, 1990
Human eosinophils express transforming growth factor alphaD T Wong, P F Weller, S J Galli, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTESK G Lim, H C Wan, P T Bozza, et al.Methods in Molecular Biology (Clifton, N.J.)|February 25, 2016
In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic DrugsPasarat Khongkow, Anna W Middleton, Anna K Middleton, et al.Pageof 48